Senior Director, Oncology Development Programs

Regeneron Pharmaceuticals, Inc.; Warren (MI); Hybrid; USD 216,000 - 360,000; Full time

Job summary

Regeneron Pharmaceuticals, Inc. is seeking a Senior Director of Development Program Management to join the Portfolio and Program Management team in a hybrid capacity.

The role focuses on leading strategy and developing a high-performing PM team across development programs, from preclinical through lifecycle management. You will drive strategic planning, resource allocation, and cross-functional collaboration with a focus on timely delivery and program excellence in oncology.

Qualifications

• Bachelor’s degree required; Master’s preferred.
• 15+ years of relevant program management experience in pharma or related industry.
• Strong written and verbal communication and cross-functional collaboration skills.
• Ability to lead and develop talent and build high-performing teams.
• Experience delivering programs from preclinical through lifecycle management.

Responsibilities

• Lead a team of program managers from manager to associate director level.
• Develop and implement training and development curricula for program managers.
• Collaborate with portfolio management to plan long-range resourcing.
• Drive strategic program teams for small to medium complexity programs.
• Deliver integrated plans with timelines and budgets aligned to company goals.

Skills

Strategic leadership

Program management

Pharma R&D

Communication skills

Talent development

Budgeting

Education

Bachelor's degree

Master's degree preferred

Tools

MS Project

Job description

Regeneron Pharmaceuticals, Inc. is seeking a Senior Director of Development Program Management to join the Portfolio and Program Management team in a hybrid capacity.

The role focuses on leading strategy and developing a high-performing PM team across development programs, from preclinical through lifecycle management. You will drive strategic planning, resource allocation, and cross-functional collaboration with a focus on timely delivery and program excellence in oncology.